bridging science with industry

Inorgen: a European advisory translating research into therapies


Inorgen is an advisory who taps the research potential of academia and research institutions, providing them a way to translate breakthrough discoveries from research into therapies for patients.

Inorgen operates with an entrepreneurial approach in the biopharma industry, with the following activities:

  • Venture Capital / Board & Advisory Business Development
  • Management / Advisory to biopharma
  • Venture Building / Entrepreneur In Residence / Translation of research into therapies and for successful exits


Discover more on: